• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

荷兰因不良事件导致住院的直接医疗费用。

Direct health care costs of hospital admissions due to adverse events in The Netherlands.

作者信息

Magdelijns Fabienne J H, Stassen Patricia M, Stehouwer Coen D A, Pijpers Evelien

机构信息

1 Division of General Medicine, Department of Internal Medicine, Maastricht University Medical Centre, Maastricht University, Maastricht, The Netherlands

1 Division of General Medicine, Department of Internal Medicine, Maastricht University Medical Centre, Maastricht University, Maastricht, The Netherlands 2 Division of Acute Medicine, Department of Internal Medicine, Maastricht University Medical Centre, Maastricht University, Maastricht, The Netherlands 3 School of CAPHRI, Maastricht University Medical Centre, Maastricht University, Maastricht, The Netherlands.

出版信息

Eur J Public Health. 2014 Dec;24(6):1028-33. doi: 10.1093/eurpub/cku037. Epub 2014 Apr 2.

DOI:10.1093/eurpub/cku037
PMID:24699427
Abstract

BACKGROUND

Health care-related adverse events (AEs) are common, and the economic burden is substantial. Information on costs of health care-related AEs 'leading' to hospitalization is limited and has focused on adverse drug events.

AIM

To provide insight into costs of admissions due to (preventable) health care-related AEs, not limited to adverse drug events.

METHODS

This study was conducted during a 5-month period (May-September 2010) in The Netherlands, in a 600-bed university medical centre. All patients who were admitted via the emergency department to an internal medicine department because of a health care-related AE were included. We retrospectively retrieved all data on medical information as well as health care resource utilization from the patient's medical record. The cost of the admission was estimated (for each patient individually) by multiplying the number of resources by their specific unit cost and then summing all costs per patient.

RESULTS

In total, 324 admissions due to a health care-related AE were included (28.7% of all admissions). Total direct health care costs of these hospitalizations amounted to €1,404,070 in a 5-month period. Medication-related AEs were most common (43.5%) and contributed most to the costs (€587,550; 41.8%). Inpatient days were most expensive (€1,076,385; 77.3%). Preventable health care-related AEs accounted for €277,665 (19.8%).

CONCLUSION

We found that health care-related AEs are expensive, with preventable health care-related AEs accounting for one-fifth of the costs. Awareness of possible health care-related AEs following medical actions is necessary to reduce already high health care costs.

摘要

背景

与医疗保健相关的不良事件(AE)很常见,经济负担巨大。关于“导致”住院的与医疗保健相关不良事件的成本信息有限,且主要集中在药物不良事件上。

目的

深入了解因(可预防的)与医疗保健相关不良事件导致的住院成本,不限于药物不良事件。

方法

本研究于2010年5月至9月在荷兰一家拥有600张床位的大学医学中心进行了为期5个月的研究。纳入所有因与医疗保健相关的不良事件通过急诊科收治到内科的患者。我们从患者病历中回顾性检索了所有医疗信息以及医疗保健资源利用数据。通过将资源数量乘以其特定单位成本,然后汇总每位患者所有成本来估算住院成本(针对每位患者单独估算)。

结果

总共纳入了324例因与医疗保健相关不良事件导致的住院病例(占所有住院病例的28.7%)。在5个月期间,这些住院病例的直接医疗总成本达1,404,070欧元。与药物相关的不良事件最为常见(43.5%),且对成本贡献最大(587,550欧元;41.8%)。住院天数成本最高(1,076,385欧元;77.3%)。可预防的与医疗保健相关不良事件占277,665欧元(19.8%)。

结论

我们发现与医疗保健相关的不良事件成本高昂,其中可预防的与医疗保健相关不良事件占成本的五分之一。为降低本已高昂的医疗保健成本,有必要提高对医疗行为后可能出现的与医疗保健相关不良事件 的认识。

相似文献

1
Direct health care costs of hospital admissions due to adverse events in The Netherlands.荷兰因不良事件导致住院的直接医疗费用。
Eur J Public Health. 2014 Dec;24(6):1028-33. doi: 10.1093/eurpub/cku037. Epub 2014 Apr 2.
2
Direct medical costs of adverse events in Dutch hospitals.荷兰医院不良事件的直接医疗费用。
BMC Health Serv Res. 2009 Feb 9;9:27. doi: 10.1186/1472-6963-9-27.
3
Preventable hospital admissions related to medication (HARM): cost analysis of the HARM study.可预防的与药物相关的医院入院(HARM):HARM 研究的成本分析。
Value Health. 2011 Jan;14(1):34-40. doi: 10.1016/j.jval.2010.10.024.
4
Acute Hospital Admissions Because of Health Care-Related Adverse Events: A Retrospective Study of 5 Specialist Departments.因医疗相关不良事件导致的急性住院:对5个专科部门的回顾性研究
J Am Med Dir Assoc. 2015 Dec;16(12):1055-61. doi: 10.1016/j.jamda.2015.06.019. Epub 2015 Aug 6.
5
Adverse events and potentially preventable deaths in Dutch hospitals: results of a retrospective patient record review study.荷兰医院中的不良事件及潜在可预防死亡:一项回顾性患者病历审查研究的结果
Qual Saf Health Care. 2009 Aug;18(4):297-302. doi: 10.1136/qshc.2007.025924.
6
Excess length of stay and economic consequences of adverse events in Dutch hospital patients.荷兰医院患者的住院时间过长及不良事件的经济后果。
BMC Health Serv Res. 2015 Dec 1;15:531. doi: 10.1186/s12913-015-1205-5.
7
Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.加拿大一所三级护理大学医院中炎症性肠病患者的直接住院费用。
Am J Gastroenterol. 2000 Mar;95(3):677-83. doi: 10.1111/j.1572-0241.2000.01845.x.
8
Health-care-related adverse events leading to admission in older individuals: incidence, predictive factors and consequences.导致老年人入院的医疗相关不良事件:发生率、预测因素及后果。
Eur J Public Health. 2016 Oct;26(5):743-748. doi: 10.1093/eurpub/ckw021. Epub 2016 Mar 21.
9
Costs of adverse drug events in German hospitals--a microcosting study.德国医院药物不良反应的成本——一项微观成本研究。
Value Health. 2012 Sep-Oct;15(6):868-75. doi: 10.1016/j.jval.2012.05.007. Epub 2012 Aug 9.
10
Costs of osteoporosis related fractures in hospital admitted patients, Tigrai, Northern Ethiopia: a retrospective study.埃塞俄比亚北部提格雷地区住院患者骨质疏松相关骨折的费用:一项回顾性研究。
Ethiop Med J. 2013 Jul;51(3):177-86.

引用本文的文献

1
Factors Influencing the Intentions of Patients With Inflammatory Rheumatic Diseases to Use a Digital Human for Medication Information: Qualitative Study.影响炎性风湿性疾病患者使用数字人获取用药信息意愿的因素:定性研究
J Med Internet Res. 2025 Mar 13;27:e57697. doi: 10.2196/57697.
2
Medication reviews by emergency department pharmacists in patients hospitalised for an adverse drug event: a cost study.急诊科药师对因药物不良事件住院患者进行药物治疗评估:一项成本研究。
BMC Health Serv Res. 2024 Aug 23;24(1):975. doi: 10.1186/s12913-024-11346-9.
3
Addressing Glucocorticoid-Related Problems with the Clinical Pharmacist Collaboration in Rheumatology Practice: A Prospective Follow-Up Study.
在风湿病实践中通过临床药师合作解决糖皮质激素相关问题:一项前瞻性随访研究。
Rheumatol Ther. 2024 Aug;11(4):1043-1055. doi: 10.1007/s40744-024-00692-z. Epub 2024 Jun 26.
4
Cohort profile for development of machine learning models to predict healthcare-related adverse events (Demeter): clinical objectives, data requirements for modelling and overview of data set for 2016-2018.队列资料简介:开发机器学习模型以预测与医疗保健相关的不良事件(Demeter):临床目标、建模数据要求以及 2016-2018 年数据集概述。
BMJ Open. 2023 Aug 17;13(8):e070929. doi: 10.1136/bmjopen-2022-070929.
5
Factors Influencing Preferences of Patients With Rheumatic Diseases Regarding Telehealth Channels for Support With Medication Use: Qualitative Study.影响风湿性疾病患者对药物使用支持的远程医疗渠道偏好的因素:定性研究
JMIR Form Res. 2023 Jul 20;7:e45086. doi: 10.2196/45086.
6
Drug-related problems reported by patients with rheumatic diseases: an observational study.风湿性疾病患者报告的药物相关问题:一项观察性研究。
BMC Rheumatol. 2023 Apr 18;7(1):7. doi: 10.1186/s41927-023-00326-x.
7
Real-World Patient Characteristics, Utilization Patterns, and Outcomes of US Patients with HR+, HER2- Metastatic Breast Cancer Treated with Abemaciclib.使用阿贝西利治疗的HR +、HER2 - 转移性乳腺癌美国患者的真实世界患者特征、使用模式及结局
Drugs Real World Outcomes. 2022 Dec;9(4):681-693. doi: 10.1007/s40801-022-00327-1. Epub 2022 Sep 12.
8
Health service use and costs associated with fluoroquinolone-related tendon injuries.氟喹诺酮类相关肌腱损伤的医疗服务利用和费用。
Pharmacol Res Perspect. 2021 May;9(3):e00796. doi: 10.1002/prp2.796.
9
The medication discrepancy detection service: A cost-effective multidisciplinary clinical approach.用药差异检测服务:一种具有成本效益的多学科临床方法。
Aten Primaria. 2021 Jan;53(1):43-50. doi: 10.1016/j.aprim.2020.04.008. Epub 2020 Sep 29.
10
A multi-stakeholder approach in optimising patients' needs in the benefit assessment process of new metastatic breast cancer treatments.多利益相关方方法在优化新转移性乳腺癌治疗的获益评估过程中患者的需求。
Breast. 2020 Aug;52:78-87. doi: 10.1016/j.breast.2020.04.011. Epub 2020 May 10.